These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 19323965

  • 1. A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.
    Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer VL, Watson SB, Breier A.
    J Clin Psychiatry; 2009 Apr; 70(4):572-81. PubMed ID: 19323965
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
    Newcomer JW, Campos JA, Marcus RN, Breder C, Berman RM, Kerselaers W, L'italien GJ, Nys M, Carson WH, McQuade RD.
    J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
    [Abstract] [Full Text] [Related]

  • 3. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.
    J Clin Psychiatry; 2004 Jul; 65 Suppl 18():47-56. PubMed ID: 15600384
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.
    Chrzanowski WK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD.
    Psychopharmacology (Berl); 2006 Dec; 189(2):259-66. PubMed ID: 17058105
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.
    Fleischhacker WW, McQuade RD, Marcus RN, Archibald D, Swanink R, Carson WH.
    Biol Psychiatry; 2009 Mar 15; 65(6):510-7. PubMed ID: 18986646
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.
    J Clin Psychopharmacol; 2008 Dec 15; 28(6):601-7. PubMed ID: 19011427
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.
    J Am Acad Child Adolesc Psychiatry; 2009 Jan 15; 48(1):60-70. PubMed ID: 19057413
    [Abstract] [Full Text] [Related]

  • 8. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
    L'Italien GJ, Casey DE, Kan HJ, Carson WH, Marcus RN.
    J Clin Psychiatry; 2007 Oct 15; 68(10):1510-6. PubMed ID: 17960964
    [Abstract] [Full Text] [Related]

  • 9. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.
    Eur Psychiatry; 2007 Oct 15; 22(7):433-43. PubMed ID: 17555947
    [Abstract] [Full Text] [Related]

  • 10. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Oct 15; 70(10):1348-57. PubMed ID: 19906340
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia.
    Ascher-Svanum H, Stensland MD, Peng X, Faries DE, Stauffer VL, Osuntokun OO, Kane JM.
    Curr Med Res Opin; 2011 Jan 15; 27(1):115-22. PubMed ID: 21110749
    [Abstract] [Full Text] [Related]

  • 12. Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.
    Newcomer JW, Meyer JM, Baker RA, Eudicone JM, Pikalov A, Vester-Blokland E, McQuade RD, Crandall DT, Carson WH, Marcus RN, L'italien G.
    Schizophr Res; 2008 Dec 15; 106(2-3):300-7. PubMed ID: 18973991
    [Abstract] [Full Text] [Related]

  • 13. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
    Kane JM, Meltzer HY, Carson WH, McQuade RD, Marcus RN, Sanchez R, Aripiprazole Study Group.
    J Clin Psychiatry; 2007 Feb 15; 68(2):213-23. PubMed ID: 17335319
    [Abstract] [Full Text] [Related]

  • 14. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
    Jin H, Shih PA, Golshan S, Mudaliar S, Henry R, Glorioso DK, Arndt S, Kraemer HC, Jeste DV.
    J Clin Psychiatry; 2013 Jan 15; 74(1):10-8. PubMed ID: 23218100
    [Abstract] [Full Text] [Related]

  • 15. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS, Ahn YM, Park HJ, Lee KY, Kim SH, Kang UG, Kim YS.
    J Clin Psychiatry; 2008 May 15; 69(5):720-31. PubMed ID: 18370574
    [Abstract] [Full Text] [Related]

  • 16. A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
    Adams DH, Kinon BJ, Baygani S, Millen BA, Velona I, Kollack-Walker S, Walling DP.
    BMC Psychiatry; 2013 May 22; 13():143. PubMed ID: 23694720
    [Abstract] [Full Text] [Related]

  • 17. Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from India.
    Jindal KC, Singh GP, Munjal V.
    Int J Psychiatry Clin Pract; 2013 Feb 22; 17(1):21-9. PubMed ID: 22339214
    [Abstract] [Full Text] [Related]

  • 18. An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia.
    Lauriello J, Lambert T, Andersen S, Lin D, Taylor CC, McDonnell D.
    J Clin Psychiatry; 2008 May 22; 69(5):790-9. PubMed ID: 18452346
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P, Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, El-Sayeh HG, Leucht S.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD006569. PubMed ID: 23450570
    [Abstract] [Full Text] [Related]

  • 20. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH.
    Am J Psychiatry; 2008 Nov 28; 165(11):1432-41. PubMed ID: 18765484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.